Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 57 of 58, showing 10 Applications out of 576 total, starting on record 561, ending on 570

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

561.

ECCT/23/02/03   INTREPiD
    Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy with High-Sensitivity Diagnostics (INTREPiD).   
Principal Investigator(s)
1. Steve M Taylor
2. Jeremiah K Laktabai
Site(s) in Kenya
Bungoma County
 
23-07-2023 View

562.

ECCT/24/04/05   Phase III Vitiligo Study
                                                                             A Double-Arm, Open Label, Phase III Study to Compare the                                           Efficacy and Safety of SCENESSE® and Narrow-Band Ultraviolet B (NB-UVB) Light versus NB-                                                                                    UVB Light Alone in the Treatment of Vitiligo   
Principal Investigator(s)
1. Dr. Hannah Wanyika Wanyika
Site(s) in Kenya
Kenyatta National Hospital -
 
30-08-2024 View

563.

ECCT/22/01/01   ASTEFANIA
    A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ADJUVANT ATEZOLIZUMAB OR PLACEBO AND TRASTUZUMAB EMTANSINE FOR HER2-POSITIVE BREAST CANCER AT HIGH RISK OF RECURRENCE FOLLOWING PREOPERATIVE THERAPY   
Principal Investigator(s)
1. Mansoor Saleh
2. Fredrick Chite Asirwa
Site(s) in Kenya
1. Aga Khan University, Nairobi (Nairobi City county)
2. International Cancer Institute (Uasin Gishu county)
 
21-07-2022 View

564.

ECCT/26/02/01   E-MASTER STUDY: PHASE 1
      Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study (E-MASTER: PHASE 1)        
Principal Investigator(s)
1. Zahida Qureshi
2. Alfred Osoti
3. George Gwako
Site(s) in Kenya
1. Mbagathi County Referral Hospital (Nairobi City county)
 
19-06-2026 View

565.

ECCT/19/06/03   Evaluation of the RTS,S vaccine implementation in Kenya (MVPE)
      An evaluation of the cluster-randomised pilot implementation of the RTS,S/AS01 malaria vaccine through routine health systems in western Kenya         
Principal Investigator(s)
1. Aaron Samuels Samuels
Site(s) in Kenya
1. Bungoma County (Bung\'oma county)
2. Busia County (Busia county)
3. Homa Bay (Homa Bay county)
4. Kakamega County (Kakamega county)
5. Kisumu County (Kisumu county)
6. Migori County (Migori county)
7. Siaya County (Siaya county)
8. Vihiga County (Vihiga county)
 
13-08-2019 View

566.

ECCT/19/07/01   IMPROVE-2
      chemoprevention with monthly IPTp with dihydroartemisinin-piperaquine for malaria in HIV-infected pregnant participants on daily cotrimoxazole in Kenya and Malawi: a multi-centre placebo-controlled trial(IMPROVE-2).    
Principal Investigator(s)
1. Hellen Cherono Barsosio
2. Simon Kariuki
Site(s) in Kenya
1. Ahero Sub-County Hospital (Kisumu county)
2. Rabuor Sub-County Hospital (Kisumu county)
3. Akala Sub-County Hospital (Siaya county)
 
03-10-2019 View

567.

ECCT/22/05/02   BREATHER Plus
        A randomised open-label 2-arm, 96-week trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily dolutegravir/tenofovir-based triple ART in virologically suppressed HIV-infected adolescents aged 12 to 19 years of age in sub-Saharan Africa   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
Moi University Clinical Research Centre
 
25-09-2022 View

568.

ECCT/25/02/01   IMPAACT 2037
    Open-Label, Phase I Study of the Safety and Pharmacokinetics of PGT121.414.LS alone and in combination with VRC07-523LS in Infants Exposed to HIV-1   
Principal Investigator(s)
1. Lucy C. Koech
Site(s) in Kenya
Kenya Medical Research Institute/Walter Reed Project
 
18-12-2025 View

569.

ECCT/22/06/01   The INSIGHT cohort
      A cohort for evaluation of open-label PrEP delivery and PrEP preferences among African women        
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
KEMRI RCTP, LUMUMBA SUBCOUNTY HOSPITAL
 
16-08-2022 View

570.

ECCT/23/03/05   SKY-06
    A PHASE II/III, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF TIRAGOLUMAB IN COMBINATION WITH ATEZOLIZUMAB PLUS   PEMETREXED AND CARBOPLATIN/CISPLATIN VERSUS PEMBROLIZUMAB PLUS PEMETREXED AND CARBOPLATIN/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER   
Principal Investigator(s)
1. Dr Primus Ochieng
Site(s) in Kenya
1. University of Nairobi -Institute of Tropical and Infectious Diseases (Nairobi City county)
2. International Cancer Institute (Uasin Gishu county)
 
11-08-2023 View